Citation: Hanyong Wang, Xinyu Yang, Chunyan Hu, Chenlu Huang, Hai Wang, Dunwan Zhu, Linhua Zhang. Programmed polymersomes with spatio-temporal delivery of antigen and dual-adjuvants for efficient dendritic cells-based cancer immunotherapy[J]. Chinese Chemical Letters, ;2022, 33(9): 4179-4184. doi: 10.1016/j.cclet.2022.02.022 shu

Programmed polymersomes with spatio-temporal delivery of antigen and dual-adjuvants for efficient dendritic cells-based cancer immunotherapy

Tianjin Key Laboratory of Biomedical Materials, Key Laboratory of Biomaterials and Nanotechnology for Cancer Immunotherapy, Institute of Biomedical Engineering, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin 300192, China

zhudunwan@bme.pumc.edu.cn

zhanglinhua@bme.pumc.edu.cn

Received Date: 26 November 2021
Revised Date: 7 February 2022
Accepted Date: 9 February 2022
Available Online: 15 February 2022

Figures(4)

Since antigen and adjuvant are rapid clearance in vivo, insufficient delivery to induce dendritic cells (DCs) maturation and cross-presentation, as well as limited migration efficiency of DCs to secondary lymph organs, greatly hinders the development of DCs-based immunotherapy. Herein, PCL-PEG-PCL polymersomes (PCEP-PS) as antigen and adjuvants delivery nanoplatforms (IMO-PS) were well-designed, which can electrostatically adsorb OVA antigen on the surface via DOTAP lipid and effectively encapsulate OVA antigen into the inner hydrophilic cavity to achieve both initial antigen exposure as well as slow and sustained antigen release, incorporate MPLA within the lipid layer to ligate with extracellular TLR4 of DCs as well as encapsulate IMQ in the hydrophobic membrane to ligate with intracellular TLR7/8 of DCs for activating synergistic immune responses via different signaling pathways. The IMO-PS significantly improved antigen uptake, promoted DCs maturation and cytokines production. DCs treated with IMO-PS could enhance migration into draining lymphoid nodes, and eventually induced antigen-specific CD8⁺ and CD4⁺ T cell responses and OVA-specific cytotoxic T lymphocyte (CTL) responses. Prophylactic vaccination of EG7-OVA tumor-bearing mice by IMO-PS + DCs significantly extended tumor-free time, effectively suppressed tumor growth, and greatly extended median survival time. The strategy may provide an effective nanoplatform for co-delivery antigen and dual-adjuvants in a spatio-temporally programmed manner for DC-based cancer immunotherapy.
- DCs vaccine,
- Immunotherapy,
- Imiquimod,
- MPLA,
- DOTAP,
- OVA
1. [1]
  J. Xiang, L. Xu, H. Gong, et al., ACS Nano 9 (2015) 6401-6411. doi: 10.1021/acsnano.5b02014
2. [2]
  K.T. Gause, A.K. Wheatley, J. Cui, et al., ACS Nano 11 (2017) 54-68. doi: 10.1021/acsnano.6b07343
3. [3]
  P. Yang, H. Song, Y. Qin, et al., Nano Lett. 18 (2018) 4377-4385. doi: 10.1021/acs.nanolett.8b01406
4. [4]
  Y. Hu, L. Lin, Z. Guo, et al., Chin. Chem. Lett. 32 (2021) 1770-1774. doi: 10.1016/j.cclet.2020.12.055
5. [5]
  K. Palucka, J. Banchereau, Immunity 39 (2013) 38-48. doi: 10.1016/j.immuni.2013.07.004
6. [6]
  P.N. Kelly, C.S.J. Ash, Science 368 (2020) 841-842. doi: 10.1126/science.2020.368.6493.twil
7. [7]
  M. Saxena, N. Bhardwaj, Trends Cancer 4 (2018) 119-137. doi: 10.1016/j.trecan.2017.12.007
8. [8]
  C.R. Perez, M. de Palma, Nat. Commun. 10 (2019) 5408. doi: 10.1038/s41467-019-13368-y
9. [9]
  L. Shen, T. Zhou, Y. Fan, et al., Chin. Chem. Lett. 31 (2020) 1709-1716. doi: 10.1016/j.cclet.2020.02.007
10. [10]
  D.J. Irvine, M.C. Hanson, K. Rakhra, T. Tokatlian, Chem. Rev. 115 (2015) 11109-11146. doi: 10.1021/acs.chemrev.5b00109
11. [11]
  M. Luo, L.Z. Samandi, Z. Wang, J.Z. Chen, J. Gao, J. Control. Release 263 (2017) 200-210. doi: 10.1016/j.jconrel.2017.03.033
12. [12]
  X. Feng, W. Xu, Z. Li, et al., Adv. Sci. (Weinh. ) 17 (2019) 1900101.
13. [13]
  M. Rincon-Restrepo, A. Mayer, S. Hauert, et al., Biomaterials 132 (2017) 48-58. doi: 10.1016/j.biomaterials.2017.03.047
14. [14]
  N. Zhang, H. Chen, Y. Fan, et al., ACS Nano 12 (2018) 4025-4035. doi: 10.1021/acsnano.8b01755
15. [15]
  L. Zhang, S. Wu, Y. Qin, et al., Nano Lett. 19 (2019) 4237-4249. doi: 10.1021/acs.nanolett.9b00030
16. [16]
  Y. Fan, P. Sahdev, L.J. Ochyl, J. Akerberg, J.J. Moon, J. Control. Release 208 (2015) 121-129. doi: 10.1016/j.jconrel.2015.04.010
17. [17]
  B. Pulendran, R. Ahmed, Nat. Immunol. 12 (2011) 509-517. doi: 10.1038/ni.2039
18. [18]
  Y. Sun, X. Feng, C. Wan, et al., Asian J. Pharm. Sci. 16 (2021) 129-132. doi: 10.1016/j.ajps.2020.05.004
19. [19]
  K.A. Fitzgerald, J.C. Kagan, Cell 180 (2020) 1044-1066. doi: 10.1016/j.cell.2020.02.041
20. [20]
  Z. Wang, Q. Chen, H. Zhu, et al., Chin. Chem. Lett. 32 (2021) 1888-1892. doi: 10.1016/j.cclet.2021.01.036
21. [21]
  F. Askarian, T. Wagner, M. Johannessen, V. Nizet, FEMS Microbiol. Rev. 42 (2018) 656-671. doi: 10.1093/femsre/fuy025
22. [22]
  H. Zhang, J. Zhang, Q. Li, et al., Biomaterials 245 (2020) 119983. doi: 10.1016/j.biomaterials.2020.119983
23. [23]
  Y. Ji, J. An, D. Hwang, et al., Metab. Eng. 57 (2020) 193-202. doi: 10.1016/j.ymben.2019.11.009
24. [24]
  R. Cheng, F. Fontana, J. Xiao, et al., ACS Appl. Mater. Interfaces 12 (2020) 44554-44562. doi: 10.1021/acsami.0c15057
25. [25]
  D. Zhu, C. Hu, F. Fan, et al., Biomaterials 206 (2019) 25-40. doi: 10.1016/j.biomaterials.2019.03.012
26. [26]
  G. Trinchieri, A. Sher, Nat. Rev. Immunol. 7 (2007) 179-190.
27. [27]
  J.K. Tom, E.Y. Dotsey, H.Y. Wong, et al., ACS Cent. Sci. 1 (2015) 439-448. doi: 10.1021/acscentsci.5b00274
28. [28]
  K.K. Short, S.M. Miller, L. Walsh, et al., J. Control. Release 315 (2019) 186-196. doi: 10.1016/j.jconrel.2019.10.025
29. [29]
  M. Kwissa, H.I. Nakaya, H. Oluoch, B. Pulendran, Blood 119 (2012) 2044-2055. doi: 10.1182/blood-2011-10-388579
30. [30]
  S. Rahmani, S. Ashraf, R. Hartmann, et al., Bioeng. Transl. Med. 1 (2016) 82-93. doi: 10.1002/btm2.10010
31. [31]
  S. Srivastava, P.S. Grace, J.D. Ernst, Cell Host Microbe 19 (2016) 44-54. doi: 10.1016/j.chom.2015.12.003
32. [32]
  M. Damo, D.S. Wilson, E.A. Watkins, J.A. Hubbell, Front. Immunol. 12 (2021) 555095. doi: 10.3389/fimmu.2021.555095
33. [33]
  P. Zhang, B. Ding, Z. Jiang, et al., Nano Lett. 21 (2021) 2088-2093. doi: 10.1021/acs.nanolett.0c04778
34. [34]
  J. Lu, Y. Jiao, G. Cao, Z. Liu, Chem. Eng. J. 420 (2021) 129746. doi: 10.1016/j.cej.2021.129746
35. [35]
  S. Iranpour, V. Nejati, N. Delirezh, P. Biparva, S. Shirian, J. Exp. Clin. Cancer Res. 35 (2016) 168. doi: 10.1186/s13046-016-0444-6
36. [36]
  J. Ma, F. Liu, W. She, et al., Nano Lett. 20 (2020) 4084-4094. doi: 10.1021/acs.nanolett.9b05171
37. [37]
  D.U. Lee, J.Y. Park, S. Kwon, et al., Nanoscale 11 (2019) 19980-19993. doi: 10.1039/C9NR04323C
38. [38]
  C. Pollard, J. Rejman, W. De Haes, et al., Mol. Ther. 21 (2013) 251-259. doi: 10.1038/mt.2012.202
39. [39]
  H. Iwamoto, T. Ojima, J. Kitadani, et al., J. Clin. Oncol. 34 (2016) 768. doi: 10.1200/JCO.2015.65.1042
40. [40]
  M.C. Takenaka, F.J. Quintana, Semin. Immunopathol. 39 (2017) 113-120. doi: 10.1007/s00281-016-0587-8
41. [41]
  X. Yang, K. Lian, T. Meng, et al., ACS Appl. Mater. Interfaces 10 (2018) 33532-33544. doi: 10.1021/acsami.8b10081
42. [42]
  R. Lorenzetti, I. Janowska, C.R. Smulski, et al., J. Autoimmun. 101 (2019) 145-152. doi: 10.1016/j.jaut.2019.04.016
43. [43]
  C. Qiao, J. Liu, J. Yang, et al., Biomaterials 85 (2016) 1-17. doi: 10.1016/j.biomaterials.2016.01.054
44. [44]
  T.C.B. Klauber, J.M. Laursen, D. Zucker, et al., Acta Biomater. 53 (2017) 367-377. doi: 10.1016/j.actbio.2017.01.072
45. [45]
  C. Huang, N. Mendez, O.H. Echeagaray, et al., ACS Appl. Mater. Interfaces 11 (2019) 26637-26647. doi: 10.1021/acsami.9b08295
46. [46]
  S. Varikuti, S. Oghumu, G. Natarajan, et al., Int. Immunol. 30 (2018) 385. doi: 10.1093/intimm/dxy037
47. [47]
  A. Teijeira, E. Russo, C. Halin, Semin. Immunopathol. 36 (2014) 261-274. doi: 10.1007/s00281-013-0410-8
48. [48]
  A. Ruiz-de-Angulo, A. Zabaleta, V. Gómez-Vallejo, J. Llop, J.C. Mareque-Rivas, ACS Nano 10 (2016) 1602-1618. doi: 10.1021/acsnano.5b07253
49. [49]
  R.L. Sabado, N. Bhardwaj, Nature 519 (2015) 300-301. doi: 10.1038/nature14211
50. [50]
  N. Seyfizadeh, R. Muthuswamy, D.A. Mitchell, S. Nierkens, N. Seyfizadeh, Crit. Rev. Oncol. Hematol. 107 (2016) 100-110. doi: 10.1016/j.critrevonc.2016.09.002
51. [51]
  X. Dong, J. Liang, A. Yang, et al., ACS Appl. Mater. Interfaces 11 (2019) 4876-4888. doi: 10.1021/acsami.8b20364
52. [52]
  J. Maggi, K. Schinnerling, B. Pesce, et al., Front. Immunol. 7 (2016) 359.
53. [53]
  R. Kuai, X. Sun, W. Yuan, et al., J. Control. Release 282 (2018) 131-139. doi: 10.1016/j.jconrel.2018.04.041
54. [54]
  P. Wang, S. Dong, P. Zhao, X. He, M. Chen, Biomaterials 182 (2018) 92-103. doi: 10.1016/j.biomaterials.2018.08.008
55. [55]
  F. Dotiwala, S. Mulik, R.B. Polidoro, et al., Nat. Med. 22 (2016) 210-216. doi: 10.1038/nm.4023
56. [56]
  M. Huang, L.T. Nicholson, K.A. Batich, et al., J. Clin. Invest. 130 (2020) 774-788. doi: 10.1172/JCI128267
1. [1]
  Liangliang Jia , Ye Hong , Xinyu He , Ying Zhou , Liujiao Ren , Hongjun Du , Bin Zhao , Bin Qin , Zhe Yang , Di Gao . Fighting hypoxia to improve photodynamic therapy-driven immunotherapy: Alleviating, exploiting and disregarding. Chinese Chemical Letters, 2025, 36(2): 109957-. doi: 10.1016/j.cclet.2024.109957
2. [2]
  Chenlu Huang , Xinyu Yang , Qingyu Yu , Linhua Zhang , Dunwan Zhu . Gas-generating polymersomes-based amplified photoimmunotherapy for abscopal effect and tumor metastasis inhibition. Chinese Chemical Letters, 2024, 35(6): 109680-. doi: 10.1016/j.cclet.2024.109680
3. [3]
  Junjie Wang , Yan Wang , Zhengdong Li , Changqiang Xie , Musammir Khan , Xingzhou Peng , Fabiao Yu . Triphenylamine-AIEgens photoactive materials for cancer theranostics. Chinese Chemical Letters, 2024, 35(6): 108934-. doi: 10.1016/j.cclet.2023.108934
4. [4]
  Xinyue Lan , Junguang Liang , Churan Wen , Xiaolong Quan , Huimin Lin , Qinqin Xu , Peixian Chen , Guangyu Yao , Dan Zhou , Meng Yu . Photo-manipulated polyunsaturated fatty acid-doped liposomal hydrogel for flexible photoimmunotherapy. Chinese Chemical Letters, 2024, 35(4): 108616-. doi: 10.1016/j.cclet.2023.108616
5. [5]
  Bohan Chen , Liming Gong , Jing Feng , Mingji Jin , Liqing Chen , Zhonggao Gao , Wei Huang . Research advances of nanoparticles for CAR-T therapy in solid tumors. Chinese Chemical Letters, 2024, 35(9): 109432-. doi: 10.1016/j.cclet.2023.109432
6. [6]
  Jiechen Liu , Xiaoguang Li , Ruiyang Xia , Yuqi Wang , Fenghe Zhang , Yongzhi Pang , Qing Li . Efficient suppression of oral squamous cell carcinoma through spatial dimension conversion drug delivery systems-enabled immunomodulatory-photodynamic therapy. Chinese Chemical Letters, 2024, 35(12): 109619-. doi: 10.1016/j.cclet.2024.109619
7. [7]
  Xiaofang Luo , Ye Wu , Xiaokun Zhang , Min Tang , Feiye Ju , Zuodong Qin , Gregory J Duns , Wei-Dong Zhang , Jiang-Jiang Qin , Xin Luan . Peptide-based strategies for overcoming multidrug-resistance in cancer therapy. Chinese Chemical Letters, 2025, 36(1): 109724-. doi: 10.1016/j.cclet.2024.109724
8. [8]
  Shuyu Liu , Xiaomin Sun , Bohan Song , Gaofeng Zeng , Bingbing Du , Chongshen Guo , Cong Wang , Lei Wang . Design and Fabrication of Phospholipid-Vesicle-based Artificial Cells towards Biomedical Applications. University Chemistry, 2024, 39(11): 182-188. doi: 10.12461/PKU.DXHX202404113
9. [9]
  Yuxin Tian , Mengjun Li , Yang Yang , Chunhui Li , Yun Peng , Haiyin Yang , Mengyuan Zhao , Pengfei Wu , Shaobo Ruan , Yuanyu Huang , Chenguang Shen , Minghui Yang . An MPXV mRNA-LNP vaccine candidate elicits protective immune responses against monkeypox virus. Chinese Chemical Letters, 2024, 35(8): 109270-. doi: 10.1016/j.cclet.2023.109270

Get Citation

PDF

XML

Metrics

PDF Downloads(2)
Abstract views(528)
HTML views(40)

通讯作者: 陈斌, bchen63@163.com

1.
沈阳化工大学材料科学与工程学院沈阳 110142